MAXCYTE, INC. (MXCT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $20.07M | -28.0% |
| 2024 | $27.88M | -40.0% |
| 2023 | $46.51M | +320.3% |
| 2022 | $11.06M | -76.8% |
| 2021 | $47.78M | +154.8% |
| 2020 | $18.76M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $20.07M | -28.0% |
| 2024 | $27.88M | -40.0% |
| 2023 | $46.51M | +320.3% |
| 2022 | $11.06M | -76.8% |
| 2021 | $47.78M | +154.8% |
| 2020 | $18.76M | — |